The U.K.'s National Institute for Health and Clinical Excellence (NICE) has changed its policy on the Alzheimer's drugs Aricept, Exelon and Reminyl. Previously the drugs could only be prescribed to people with moderate to severe symptoms but they can now be prescribed to people with milder symptoms as well. The drugs cost around £2.80 per day and slow down the progress of the disease helping people put their affairs in order and stay independent for longer. A fourth drug, Ebixa, which was previously only given late in the progression of the disease can also now be prescribed earlier.
You can find out more about this story here.